| FDA APPROVALS First generic Abilify to treat mental illnesses Cyramza for stomach cancer |
 |
Multiple Sclerosis Drug Prices Rose at an ‘Alarming’ Rate: Study
Wall Street Journal - April 24, 2015
There has been an “alarming rise” in the cost of multiple sclerosis treatments over the past dozen years and the cost of these drugs increased at rates well beyond the overall growth in prescription drug prices, according to a new study.
Administration bears down on states to expand Medicaid
Modern Healthcare - April 25, 2015
Jim Nathan, CEO of Fort Myers, Fla.-based Lee Memorial Health System, is watching his state's ferocious political battle over Medicaid expansion with growing concern. The stakes are high for his system's three hospitals.
Could High-Dose Insulin Prevent Type 1 Diabetes in High-Risk Kids?
HealthDay News - April 21, 2015
Study found daily capsules of the natural hormone triggered protective immune response.
Newly Insured Shift Prescription Trends Substantially
Pharmacy Times - April 18, 2015
The first full year of enrollment under expanded Medicaid and Health Insurance Exchanges (HIX) had a substantial impact on health care spending in 2014.
HHS to investigate price spikes for generic drugs
Drug Topics - April 20, 2015
The Office of Inspector General of the U.S. Department of Health & Human Services (HHS) recently announced it would investigate price increases for generic drugs in the Medicaid drug rebate program.
Pharmaceutical Companies Buy Rivals’ Drugs, Then Jack Up the Prices
Wall Street Journal - April 26, 2015
On Feb. 10, Valeant Pharmaceuticals International Inc. bought the rights to a pair of life-saving heart drugs. The same day, their list prices rose by 525% and 212%.
New Drug Class Slashes 'Bad' Cholesterol, Review Finds
HealthDay News - April 27, 2015
If approved, medications could be used by people who don't respond to statins.
Why researchers say fake and low-quality drugs are a ‘global pandemic’
Washington Post - April 20, 2015
Fake and substandard drugs are responsible for tens of thousands of deaths around the globe each year, and the persistent lack of reliable medicines in poor countries threatens to roll back decades of efforts to combat malaria, tuberculosis, HIV/AIDS and other conditions, researchers said Monday.
Rising Antibiotic Shortages Raise Concerns About Patient Care
Infection Control Today - April 23, 2015
Shortages of key antibiotics, including gold-standard therapies and drugs used to treat highly resistant infections, are on the rise, according to a new study of shortages from 2001 to 2013 published in Clinical Infectious Diseases and available online. The trends raise serious concerns about the effects on patient care, particularly for infections without effective alternative treatment options.
Contact,
Jan Tankersley
Senior Vice President, Marketing & Sales
Pharmaceutical Strategies Group (PSG)
Office: 972-943-7141
Email: JTankersley@PSGConsults.com
PSGNewsletter@PSGConsults.com
www.PSGConsults.com
 |
 |
 |